Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

A teenage patient has become the first in the UK, a hospital said, to receive what medics call a ground-breaking new drug for ...

The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12 ...

Glytec increased its customer base and overall healthcare impact significantly, driven by a combination of over 20 new and expanded client accounts. Across these new and ...

A simple scoring system could revolutionize how doctors prevent heart attacks and strokes by identifying patients most likely ...

Background The Prognostic Nutritional Index (PNI), calculated from serum albumin levels and lymphocyte counts, is a simple ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time ...

For millions of children with Type 1 diabetes, the flu can quickly escalate into a life-threatening condition called diabetic ketoacidosis.

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...